No annual revenue total was found in BiomX Inc.'s SEC filings.
BiomX Inc. (HLSQ) files with the SEC under industry code 7372, Services-Prepackaged Software. Free cash flow was -$26.4 million. As of Jun 30, 2026 it held $572,000 in cash and investments and $478,000 in total debt.
Revenue
—
Net income (TTM)
$-45.49M
-145.0% vs year-ago TTM
Operating cash flow (TTM)
$-18.15M
+37.8% vs year-ago TTM
Free cash flow (TTM)
$-18.16M
EPS (TTM)
$-11.02
-218.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
10.11M
+534.5% vs prior year
Net cash
$94,000
as of Jun 30, 2026
Operating margin
—
Company profile
- Industry
- Services-Prepackaged Software (SIC 7372)
- Listed as
- HLSQ (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Dover, DE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1739174
- Former names
- BiomX Inc. (until Sep 9, 2026); Chardan Healthcare Acquisition Corp. (until Oct 23, 2019)
Other Services-Prepackaged Software companies
- Microsoft Corp MSFT
- Palantir Technologies Inc. PLTR
- Oracle Corp ORCL
- Sap SE SAP
- CrowdStrike Holdings, Inc. CRWD
- Shopify Inc. SHOP
- Salesforce, Inc. CRM
- ServiceNow, Inc. NOW
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$41.5M | -$44.5M | -$25.3M | -$27.2M | -$35.5M |
| Net income | -$36.2M | -$17.7M | -$26.2M | -$28.3M | -$36.2M |
| Diluted EPS | $22.19 | $58.31 | $5.10 | $0.95 | — |
| Operating cash flow | -$26.4M | -$37.0M | -$21.3M | -$29.1M | -$27.6M |
| Free cash flow | -$26.4M | -$37.0M | -$21.3M | -$29.2M | -$31.3M |
| Total assets | $5.8M | $43.2M | $25.0M | $45.5M | $78.0M |
| Stockholders' equity | -$1.3M | $24.1M | $3.1M | $21.0M | $47.5M |
| Cash and investments | $4.4M | $16.9M | $14.9M | $33.3M | $62.1M |
| Total debt | $1.4M | $9.6M | $15.1M | $19.5M | $19.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Unregistered share sale, Officer or director change, Shareholder vote results
|
Oct 23, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Oct 19, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Oct 13, 2026 | Oct 6, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 7, 2026 | Oct 7, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 5, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 29, 2026 | Sep 29, 2026 |
All 582 BiomX Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.